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OBJECTIVES To assess the feasibility and safety of exercise testing (ET) using a Bruce protocol (BPR)
within three days of an acute myocardial infarction (AMI) with the data obtained from a
prospectively managed database.
BACKGROUND Exercise testing after AMI is usually done between days 4 and 6 and often using a “low-level”
protocol. Earlier testing with BPR may allow for efficient triage.
METHODS Patients were considered for early ET when off intravenous nitroglycerine with no rest angina,
uncontrolled cardiac failure or arrhythmias.
RESULTS Of 300 consecutive AMI patients who underwent an ET, 216 (72.0%; M 5 163, F 5 53; age
mean 59 6 0.8 SEM, range 34 to 83 years) had ET within three days of admission. There
were 124 (57%) negative, 56 (26%) positive and 36 (17%) indeterminate tests. The maximum
heart rate achieved was 116 6 1 beats/min (range 64 to 163), which was 72.2 6 0.8% of
predicted maximum (86.6% on beta-adrenergic blocking agents at ET; exercise duration 5
6.7 6 0.2 min). Reasons for termination: maximum effort—89 (41%); low-level test target
(stage III/IV of BPR)—63 (29%); positive ST segment change—19 (9%); severe chest
pain—12 (5.5%); reaching 90% predicted maximum heart rate—6 (3%); nonsustained
ventricular tachycardia—1 (0.5%); other—26 (12%). Fourteen (6.5%) patients had minor
complications (i.e., drop in systolic pressure, chest pain .5 min) with no cardiac arrests,
AMIs or deaths. After the ET, 87 (40%) patients were discharged the same day, 73 (34%) the
next day.
CONCLUSIONS The majority of ETs after an AMI can be done using the Bruce protocol within three days
of admission with a very low incidence of complications. This can lead to early triage and
potential cost savings. (J Am Coll Cardiol 2000;35:1212–20) © 2000 by the American
College of Cardiology
Although the incidence of coronary artery disease has been
decreasing in developed countries over the last two to three
decades, the prevalence is expected to increase given the
rapid aging of the population (1). Acute myocardial infarc-
tion (AMI) remains the first clinical manifestation of
coronary artery disease in a significant proportion of pa-
tients. The occurrence of an AMI has considerable influence
on short-term as well as long-term morbidity and mortality
(2,3). Even though mortality during the first year after an
AMI remains relatively low (approximately 10%), about
40% to 50% of the patients experience a significant coronary
event (reinfarction, need for revascularization, development
of congestive cardiac failure) during this period (4). Further,
a majority of these coronary events appear to be concen-
trated within the first six weeks to three months after the
AMI, making early identification of these patients a priority
to hopefully alter this prognosis favorably (4). Although
limitations exist, exercise testing (ET) has remained the
most universally available method for the initial prognosti-
cation of patients with an AMI. Further, the goals and
needs of ET as well as the population that requires ET may
have undergone changes over the last 10 to 15 years because
of increasing utilization of thrombolytic therapy, primary
angioplasty or early postinfarction coronary angiography/
angioplasty before exercise testing. Generally ET is done
approximately the fifth to eighth day after AMI after a
graduated program of mobilization initially within the
coronary/intermediate care units (CICUs) followed by a
period on the medical ward (5,6). A recent review on ET
has listed an AMI within the preceding three to five days as
an absolute contraindication to exercise testing (5). Further,
the American College of Cardiology/American Heart As-
sociation guidelines for ET considers the “safety of ET”
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performed within three days after an AMI as not being
established (7). However, there has been increasing pressure
in terms of minimizing the durations of hospital stay for all
acute illnesses including AMI due to budgetary constraints
within the health care systems. If one is to continue with a
noninvasive assessment for risk stratification (to select pa-
tients for coronary angiography) in this era, one of three
strategies can be adopted: 1) early discharge followed by ET
as an outpatient over the ensuing two to six weeks, 2) ET
done very early after an AMI after a strategy of accelerated
mobilization of the patients, 3) pharmacologic stress testing
with dipyridamole-sestamibi imaging or dobutamine-stress
echocardiography. Although the third approach is likely to
offer the best sensitivity and specificity, it is more costly and
not universally available at short notice. The first approach
is safe (from the ET point of view) and feasible, but the
major disadvantage remains the early occurrence of coronary
events after an AMI (4). Thus, if one were to utilize the ET
as a means of identifying those who are likely to have events,
in the hope of minimizing their occurrence, postponing the
test could be detrimental. This is due to the fact that
arranging outpatient coronary angiography (to hopefully
consider revascularization to prevent these events in those
with positive ET) will involve more delays (in most coun-
tries) than if the procedure was performed before discharge
at the time of the index infarction. Thus, the strategy of very
early ET will be preferred whenever feasible. A handful of
studies are available on the feasibility and safety of ET
within the first three to four days of an AMI, but the
patients selected in these studies have been mostly individ-
uals who have undergone coronary angiography (and revas-
cularization if necessary) before the ET (8). However, one
could argue that this constitutes the very group where an ET
would provide the least amount of information needed for
patient management. This is because the main objective of
doing an ET (i.e., to consider coronary angiography) has
already been dealt with in this category of patient. In
addition, it is likely that after revascularization, an ET
would likely result in less complications.
Since 1995 at this institution an attempt has been made
to discharge patients with AMI directly from the coronary
care unit (9). In pursuit of this goal, an attempt is made to
perform ETs very early after the AMI to assist in risk
stratification and to decide on the feasibility of early
discharge or the need for in-hospital coronary angiography.
This investigation is an observational study with the data
obtained from a prospectively managed database.
METHODS
All patients admitted with an AMI from July 1996 to
October 1998 were included in this study. Clinical, inves-
tigational and demographic data on all patients admitted to
the CICU were collected prospectively. The constitution of
the database has been described previously (9). The diag-
nosis of an AMI was made based on the presence of at least
two of the following three criteria: 1) chest pain suggestive
of myocardial ischemia lasting 30 min or longer, 2) enzy-
matic evidence of acute myocardial necrosis, as demon-
strated by a rise in creatine kinase levels with the creatine
kinase isoenzyme–myocardial band (CK-MB) fraction be-
ing greater than 5%, 3) new electrocardiographic change
which included development of Q waves or ST/T changes
lasting 48 h or longer.
All patients with an AMI were considered as candidates
for direct discharge from the CICU with their mobilization
done in an accelerated manner. The following were used as
a guide to selecting patients for early ET: 1) absence of chest
pain/dyspnea on walking in the CICU on telemetry, 2)
absence of New York Heart Association class III/IV con-
gestive cardiac failure, 3) absence of recurrent nonsustained
ventricular tachycardia, 4) absence of atrial fibrillation with
an uncontrolled ventricular response with ambulation
within the CICU. Those patients who had ET done within
the first 3 days of their AMI were included in the study.
However, comparison was made between this group of
patients and all the other patients with an AMI who were
admitted during the same time period. The patients were
divided into five groups: 1) early ET group (EETGP)—
those patients who had ET done within 72 h of the time
recorded in the hospital admission form, 2) late ET group
(LETGP)—those patients who had ET done after three
days but before hospital discharge, 3) coronary angiography/
angioplasty group (CAGP)—those patients who did not
have an ET as they had coronary angiography/angioplasty
done due to continuing angina before consideration of an
ET, 4) coronary artery bypass surgery group (CABGP)—
those patients who underwent coronary angiography be-
cause of continuing angina before consideration of an ET
followed by coronary artery bypass surgery during their
hospital stay, 5) deceased group (DECGP)—those patients
who died during their hospital stay before an ET being
done, 6) no ET group (NETGP)—the patients who were
discharged home without a predischarge ET as they were
not deemed as able to walk on a treadmill due to reasons
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
BPR 5 Bruce protocol
CABGP 5 coronary artery bypass surgery group
CAGP 5 coronary angiography/angioplasty group
CK-MB 5 creatine kinase isoenzyme–myocardial band
CICU 5 coronary/intermediate care unit
DECGP 5 deceased group
ECG 5 electrocardiogram
EETGP 5 early exercise test group
ET 5 exercise test/testing
LETGP 5 late exercise test group
NETGP 5 no exercise test group
URV 5 unscheduled return visits
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such as poor physical mobility, lightheadedness, or dyspnea
on walking on level ground. There were some patients in the
EETGP and LETGP who underwent coronary angiogra-
phy with or without revascularization after an abnormal ET.
In the CAGP a predischarge ET after the angiography/
angioplasty was considered superfluous, and, thus, an out-
patient ET was arranged four to six weeks after discharge.
All patients had ET using an automated system (model #
Q5000, Quinton Instruments Company, Bothell, Washing-
ton). The electrocardiogram (ECG) (12-lead) was recorded
using the lead system described by Mason and Likar (10). A
12-lead ECG was recorded before exercise, at the end of
each stage of exercise, at end of exercise and 1 min, 2 min
and 4 min after completion of the exercise. Leads V3, V5
and aVF were monitored continuously with the magnitude
of ST segment depression measured 80 ms after the J-point
and the ST segment slope analyzed. Horizontal/
downsloping nett ST segment depression of .0.1 mV
observed in three consecutive beats was considered a positive
test (irrespective of the presence/absence of chest pain). The
final results were tabulated as being positive, negative or
indeterminate. The tests that were not positive together
with a maximum heart rate achieved of ,70% of the
predicted maximum or completion of ,6 min on the Bruce
protocol (BPR) were considered indeterminate. The follow-
ing end points were utilized for termination of the test: 1)
horizontal or downsloping ST depression in excess of 0.2
mV (test terminated before this in the presence of concom-
itant chest pain, typical of angina, associated with horizontal
or downsloping ST depression .0.1 millivolts); 2) fall in
systolic blood pressure of .10 mm Hg accompanied by
symptoms of lightheadedness; 3) sustained ventricular
tachycardia or frequent runs of nonsustained ventricular
tachycardia; 4) as requested by the patient, although encour-
agement was given to continue whenever no other reason
for termination was apparent; 5) at the end of stage IV of
the BPR in those patients ,60 years of age and at the end
of stage III of the BPR in those patients .60 years of age;
6) achieving 90% of the predicted maximum heart rate for
age; 7) maximum effort.
Follow-up. The postdischarge course was evaluated six
weeks after discharge by a telephone interview using a
structured questionnaire. All attempts were made to contact
the patients at home or at work. Confirmation of readmis-
sions during the six-week postdischarge period was obtained
from discharge summaries. Visits to the physicians arranged
at the time of discharge were regarded as scheduled visits.
All other visits to physicians, together with all readmissions,
were categorized as unscheduled return visits (URV). All
patients were also contacted at approximately one year after
hospital discharge.
Statistical analysis. All data were entered into a database
formulated within the SPSS data management systems.
Continuous variables were entered as such with all discrete
variables categorized to ensure that responses would fall into
mutually exclusive categories. The cross-tabulations were
done on discrete variables using a chi-square test. Analyses
on continuous variables were made using a one-way analysis
of variance. The least significance difference test was used to
determine the statistical significance of differences between
groups whenever the F value was significant. A p value of
,0.05 is quoted for all analyses, accepting the limitation of
this value with multiple comparisons that are inherent in
any observational study. Thus, the p value by itself should
not be accepted as demonstrating a clinically significant
difference between groups.
The follow-up data between the groups was analyzed
using an analysis of variance. After this, the significance of
the differences between individual groups was made using
Bonferonni’s intervals to make allowances for multiple
comparisons (this was done whenever the F value was
significant). A discriminant function analysis was carried
out to determine whether the individuals who died within a
year of discharge could be identified at the time of dis-
charge. The details of the methodology has been described
previously (4). In summary, all variables considered as
having a possible impact on posthospital mortality were
entered into a stepwise discriminant function analysis pro-
gram to obtain the best possible discrimination between the
two groups (i.e., one year death vs. no death). During the
analysis the variables were entered in a stepwise manner to
obtain the best possible discrimination. At each step, a
single additional variable was entered into the set of dis-
criminating variables. The variables entered were selected
on the basis of minimizing the overall Wilk’s lambda, a
generalized distance measure. The program calculated the
canonical correlation for the discriminant function and the
canonical discriminant function coefficients for each of the
discriminating variables.
The program also classified each patient into one of the
two groups (one year death vs. no death) using the “Jack-
knife” method of Lachenbruch (11). In this method, a single
patient is removed, and the discriminant function analysis is
carried out on the remaining (n 2 1) patients. The resulting
discriminant function equation is then applied to the data
from the removed patient to predict the group (one year
death or no death) to which the patient belongs. This
analysis was performed sequentially on each patient and the
predicted group compared with the actual group in each
case. This method provides a relatively unbiased estimation
of the error rate of the discriminant function analysis (11).
RESULTS
During the period of the study there were 540 patients
admitted with a diagnosis of AMI. There were 374 (69.3%)
men and 166 (30.7%) women with a mean age of 64.7 6 0.6
years (standard error of the mean). Two hundred and
sixteen (40.0%) patients received thrombolytic therapy with
alteplase or reteplase given in 132 (61.1%) patients and
streptokinase in 74 (34.3%) patients. The location of the
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AMI was anteroseptal in 181 (33.5%) and inferior/posterior
in 267 (49.5%) of the patients. The AMI was Q wave in
type in 279 (51.7%) of the patients. At discharge 410
(80.4%) were on beta-adrenergic blocking agents, and 212
(41.6%) of the patients were on angiotensin converting
enzyme inhibitors. Only 55 patients (10.8%) were on
calcium antagonists with 47.3% of these patients on a
beta-blocker as well. Thirty patients died during their
hospital stay with an in-hospital mortality rate of 5.6%.
Coronary angiography was done in 135 (25%) patients with
subsequent coronary angioplasty and bypass surgery done on
51 (9.4%) and 17 (3.1%) patients, respectively. The mean
duration of hospital stay was 4.9 6 0.1 days.
Of the 540 patients, 300 underwent a predischarge ET
(55.6%). Of these, 216 (72.0%) underwent the ET within
three days of their admission (i.e., within 72 h of the time
recorded in the hospital legal admission form). Of the 216
patients, 73 (33.9%) underwent the ET within 48 h of
admission, with 66.1% undergoing the test between 48 to
72 h of admission. The clinical characteristics and investi-
gational data on these patients are outlined in Table 1.
There were four patients with voltage criteria for left
ventricular hypertrophy with nine patients that showed ST
depression of .0.1 mV in the resting ECG. There were no
patients with left bundle branch block. A significantly
higher proportion of men (43.6%) were able to undergo the
ET within 3 days compared with the women (32.1%, p ,
0.05). The BPR was employed in 99.5% of the patients,
with one patient undergoing an ET starting at stage II of
the modified BPR in view of the uncertainty regarding the
ability to start at stage I of the BPR. The mean duration of
exercise was 6.7 6 0.2 min with a range of 1.3 to 12 min.
The exercise duration was significantly higher in the men
(p , 0.001). Thirty-three patients (15.3%) completed more
than 9 min of exercise (thus, reaching Stage IV of the BPR)
with a further 76 patients (34.7%) completing over 6 min of
exercise. The maximum heart rate attained was 116 6 1.3
(range 64–163 beats/min) for the entire group with value
being significantly higher in the men (p , 0.05). The
maximum heart attained as a percentage of the predicted
maximum heart rate for age had a mean of 72.2 6 0.8%. At
the time of the ET, 187 patients (86.6%) were on beta-
blockers. The ET results were: positive in 56 (25.9%)
patients, negative in 124 patients (57.4%), indeterminate in
36 patients (16.7%). Women had a higher incidence of
indeterminate tests (28.3% vs. 12.9% for men). Subsequent
exercise/persantine sestamibi scans were booked on nine
patients (4.2%). Following the ET, 87 patients (40.3%)
were discharged the same day, with another 73 patients
(33.8%) discharged the following day (thus, 74.1% were
discharged within 24 h).
Of the 56 patients with positive ET, 28 patients under-
went coronary angiography before discharge with 11 and 3
patients requiring coronary angioplasty and coronary artery
bypass surgery, respectively. Of the balance of 28 patients,
16 underwent coronary angiography as outpatients with 8
patients requiring coronary angioplasty and 1 patient re-
ferred for bypass surgery. Of the 36 patients with indeter-
minate tests, 12 patients underwent coronary angiography
(10 as inpatients) with 6 patients requiring coronary angio-
plasty. Thus, 38 patients (17.6%) were scheduled to have
coronary angiography as inpatients (after consideration of
the ET results), and these patients had a more prolonged
hospital stay.
The mean duration of hospital stay for the EETGP was
4.0 6 0.1 days with the value higher for the women (4.5 6
0.4 days) compared with the men (3.9 6 0.2 days) although
the difference did not achieve statistical significance (p .
0.05).
The ET was terminated due to: maximum effort in 89
patients (41.2%); worsening chest pain in 12 patients
(5.6%); significant ST segment depression in 19 patients
(8.8%); achievement of 90% of the predicted maximum
heart rate in 6 patients (2.8%); a low level test (i.e., at the
end of stage III or IV of the BPR as outlined in the
Methods section) in 63 patients (29.2%); other reasons such
Table 1. Clinical and Exercise Test Data on the Early Exercise
Test Group (n 5 216; Mean 6 Standard Error of the Mean or





Age (yrs)* 57.8 6 0.9 63.2 6 1.6
Day of Exercise Test
Within 2 days 63 (38.7%) 10 (18.9%)
Third day 100 (61.3%) 43 (81.1%)
Exercise Duration (min)* 7.2 6 0.2 5.0 6 0.3
0–3 min 7 (4.3%) 10 (18.9%)
.3–6 min 56 (34.4%) 35 (66.0%)
.6–9 min 70 (42.9%) 5 (9.4%)
.9 min 30 (18.4%) 3 (5.7%)
Peak Heart Rate (beats/min)
Achieved* 118 6 2 111 6 3
As % of predicted
maximum
72.8 6 0.9 70.7 6 1.8
Exercise Test Results
Positive 44 (27.0%) 12 (22.6%)
Negative 98 (60.2%) 26 (49.1%)
Indeterminate 21 (12.9%) 15 (28.3%)
Peak Creatine Kinase (u/l) 1492 6 293 1176 6 153
Duration of Hospital Stay
(days)




1 (0.6%) 0 (0.0%)
Drop in SBP 5 (3.1%) 2 (3.8%)
AMI/death/sustained VT 0 (0.0%) 0 (0.0%)
Nonsustained VT 1 (0.6%) 0 (0.0%)
*p , 0.05. †Chest pain or significant ST segment depression persisting for .5 min
after exercise.
AMI 5 acute myocardial infarction; SBP 5 systolic blood pressure; VT 5
ventricular tachycardia.
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as claudication, patient apprehension, presyncope in 26
patients (12%). Only one patient (0.5%) had the test
terminated due to nonsustained ventricular tachycardia.
There were no deaths, cardiac arrests, myocardial infarctions
or sustained ventricular tachycardias related to the ETs.
There were seven patients (3.2%) who had a drop in systolic
blood pressure .10 mm Hg during test, five patients (2.3%)
with persistent (lasting .5 min after termination of ET) ST
segment depression, one patient (0.6%) who had prolonged
angina (lasting .5 min after termination of ET) and one
patient (0.6%) who had transient third degree heart block as
a result of the test.
Comparative data for the five groups of patients outlined
in the Methods section are tabulated in Tables 2 and 3. The
EETGP had a significantly lower maximum creatine kinase
value, a shorter length of hospital stay and a lower percent-
age of women and diabetics compared with the LETGP
(p , 0.05). The LETGP had a higher incidence of
anteroseptal AMIs, thrombolytic therapy, congestive car-
diac failure, artificial ventilation, continuing angina and
sustained ventricular tachycardia/ventricular fibrillation
compared with the EETGP (p , 0.05). The NETGP and
the DECGP had a higher mean age and a higher incidence
of congestive cardiac failure and retired individuals com-
pared with the other groups. The DECGP had a higher
incidence of complications such as cardiogenic shock, sus-
tained ventricular tachycardia/ventricular fibrillation, third
degree heart block, need for mechanical ventilation and
inotropic agents compared with all other groups.
Follow-up information at six weeks after discharge using
a structured questionnaire was available on 492 (96.3%) of
the 510 patients’ discharged alive (Table 4). Of the 18
patients who could not be directly contacted/refused to
participate in the follow-up assessment, 13 patients were
known to be alive at six weeks after discharge (as per
information from the family physician’s office). Thus, only
five patients (0.98%) were lost to follow-up (reasons 5 out
of country patients, movement out of province with no
contact telephone number or address available). Unsched-
uled return visits, emergency room visits and readmissions
were not significantly different between the groups (p .
0.05). During this period, unscheduled return visits oc-
curred in 22.7% and 26.5% of the EETGP and LETGP,
respectively. Readmissions were lower (although not statis-
tically significant) and visits to the emergency department
similar in the EETGP compared with the LETGP. In the
EETGP 45.4% of the patients who were employed at the
time of the AMI had returned to work within six weeks (of
the AMI) compared with only 27.6% of the LETGP.
However, this difference was not statistically significant
(p . 0.05).
Follow-up information at one year after discharge is
outlined in Table 4. This information was available for 484
(97.4%) of the 497 eligible patients: that is, 540—30 (died
before discharge)—13 (has not reached one year yet). Thus,
13 patients were lost to follow-up. The NETGP had a
34.9% incidence of death during this period compared with
4.0% and 8.8% incidences in the EETGP and LETGP,
Table 2. Demographic and Historical Data on the Six Groups of Patients (n 5 540; Mean 6 Standard Error of the Mean or the
Number of Patients, With Percentages Within that Group in Brackets)
EETGP LETGP NETGP DECGP CAGP CABGP
No. of Patients 216 (40.0%) 84 (15.6%) 132 (24.4%) 29 (5.4%) 68 (12.6%) 11 (2.0%)
Age (yr) 59.0 6 0.8 61.1 6 1.4 74.6 6 1.1 75.3 6 2.1 62.8 6 1.4 67.6 6 2.7
Gender
Women* 53 (24.5%) 32 (38.1%) 52 (39.4%) 13 (44.8%) 15 (22.1%) 1 (9.1%)
Men 163 (75.5%) 52 (61.9%) 80 (60.6%) 16 (55.2%) 53 (77.9%) 10 (90.9%)
Hypertension 80 (37.0%) 50 (59.5%) 73 (55.3%) 16 (55.2%) 35 (51.5%) 4 (36.4%)
Diabetes* 32 (14.8%) 20 (23.8%) 39 (29.5%) 5 (17.2%) 16 (23.5%) 2 (18.2%)
Known Dyslipidemia 79 (37.0%) 36 (43.0%) 43 (32.6%) 3 (10.3%) 29 (42.6%) 6 (54.5%)
F/H CAD 92 (42.6%) 25 (29.8%) 29 (22.0%) 8 (27.6%) 19 (27.9%) 5 (45.5%)
Smokers
Current 89 (41.2%) 32 (38.1%) 34 (25.8%) 6 (20.7%) 25 (36.8%) 2 (18.2%)
Ever 154 (71.3%) 58 (69.0%) 84 (63.6%) 15 (51.7%) 56 (82.4%) 7 (63.6%)
History of
CCF* 5 (2.3%) 4 (4.8%) 30 (22.7%) 8 (27.6%) 8 (11.8%) 0 (0.0%)
AMI* 42 (19.4%) 17 (20.2%) 55 (41.7%) 8 (27.6%) 27 (39.7%) 7 (63.6%)
Angina* 69 (31.9%) 36 (42.9%) 68 (51.5%) 14 (48.3%) 42 (61.8%) 9 (81.8%)
PTCA 8 (3.7%) 5 (6.0%) 7 (5.3%) 1 (3.4%) 9 (13.2%) 2 (18.2%)
Retirees* 84 (39.0%) 37 (44.0%) 100 (75.8%) 24 (82.8%) 33 (48.5%) 9 (81.8%)
BMI 29.3 6 0.9 27.7 6 0.8 27.0 6 0.7 26.6 6 2.5 28.2 6 0.6 28.0 6 1.0
*p , 0.05 for the F value in the analysis of variance; significant differences between the individual groups (by the least significant difference test) are outlined in the text.
AMI 5 acute myocardial infarction; BMI 5 body mass index; CABGP 5 coronary artery bypass surgery group; CAGP 5 coronary angiography/angioplasty group; CCF 5
congestive cardiac failure; DECGP 5 deceased group; EETGP 5 early exercise test group; F/H CAD 5 family history of coronary artery disease; LETGP 5 late exercise test
group; NETGP 5 no exercise test group; PTCA 5 percutaneous transluminal coronary angioplasty.
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respectively (p , 0.001). The incidences of death in the
EETGP and LETGP were not significantly different (p .
0.05). The occurrence of congestive cardiac failure was also
significantly higher in the NETGP (12.9%) compared with
the EETGP (1.1%) and LETGP (4.2%) (p , 0.001).
However, the incidence of unstable angina and recurrent
AMI in the NETGP was not significantly different. The
EETGP appeared to have a slightly lower incidence of
death, unstable angina, congestive cardiac failure and coro-
nary angioplasty during the year after discharge compared
with the LETGP although no statistically significant dif-
ference was demonstrated.
Discriminant function analysis done with each variable
entered in a stepwise manner revealed in-hospital congestive
cardiac failure; the ET groups (as identified in this study)
and the age of the patient were the only significant inde-
pendent predictors of death within one year on those
discharged alive. The standardized canonical discriminant
function coefficients for congestive cardiac failure, ET group
and age were 0.594, 0.516 and 0.247, respectively. The
canonical correlation coefficient for the discriminant func-
tion was 0.424. The “Jack-knife” method correctly classified
76.4% of the patients.
DISCUSSION
This study examined the feasibility and safety of doing ET
using the BPR early on after an AMI while the patients are
still within the CICU. The study demonstrated that early
ETs could be performed in approximately 40% of the
patients admitted with an AMI. If the patients who died
and those who underwent early coronary angiography due to
continuing angina were excluded (as the ET was deliber-
ately omitted in the latter group although it could have been
done with an anticipated lower incidence of complications
given the prior revascularization), the percentage who un-
derwent early ET would constitute 50.0% of the total
population. Further, the EETGP constituted 72.0% of the
total number of patients who underwent ET before dis-
charge. Very few complications were noted in spite of the
BPR being used in almost all instances with the patients
exercising to the end of stage III/IV of the protocol
(depending on the age) in the absence of other end points.
Previous studies of early ET with AMI. Review of the
literature revealed only a few investigations looking at ET
within the first three days after myocardial infarction or
using symptom limited ETs during this early period. A
Table 3. Clinical and Investigational Data on the Six Groups of Patients (n 5 540; Mean 6 Standard Error of the Mean or the
Number of Patients, With Percentages Within that Group in Brackets)
EEGTP LETGP NETGP DECGP CAGP CABGP
No. of Patients 216 (40.0%) 84 (15.6%) 132 (24.4%) 29 (5.4%) 68 (12.6%) 11 (2.0%)
Location of AMI
Anteroseptal* 50 (23.1%) 37 (44.0%) 48 (36.4%) 14 (48.3%) 28 (41.2%) 4 (36.4%)
Inferior/posterior 133 (61.6%) 36 (42.9%) 50 (37.9%) 10 (34.5%) 32 (47.1%) 6 (54.4%)
Lateral 27 (12.5%) 8 (9.5%) 19 (14.4%) 3 (10.3%) 7 (10.3%) 1 (9.1%)
Indeterminate 6 (2.8%) 3 (3.6%) 15 (11.4%) 2 (6.9%) 1 (1.5%) 0 (0.0%)
Type of MI
Q wave 119 (55.1%) 54 (64.3%) 57 (43.2%) 16 (55.2%) 31 (45.6%) 2 (18.2%)
Non-Q wave 97 (44.9%) 30 (35.7%) 75 (56.8%) 13 (44.8%) 37 (54.4%) 9 (81.8%)
Maximum CK (u/l) 1441 6 225 1918 6 209 1544 6 147 3408 6 1017 1307 6 252 642 6 141
Duration of hospital stay (days) 4.0 6 0.1 5.8 6 0.2 4.9 6 0.2 2.8 6 0.7 6.2 6 0.4 12.9 6 1.4
Thrombolysis* 96 (44.4%) 52 (61.9%) 40 (30.3%) 6 (20.7%) 17 (25.0%) 5 (45.5%)
Complications
Deaths 0 (0.0%) 1 (1.2%) 0 (0.0%) 29 (100%) 0 (0.0%) 0 (0.0%)
CCF* 6 (2.8%) 17 (20.2%) 47 (35.6%) 17 (58.6%) 14 (20.0%) 1 (9.1%)
Cardiogenic shock 0 (0.0%) 0 (0.0%) 6 (4.5%) 11 (37.9%) 5 (7.4%) 0 (0.0%)
Sustained VT/VF* 5 (2.3%) 7 (8.3%) 11 (8.3%) 8 (27.6%) 6 (8.8%) 0 (0.0%)
3° Heart block 5 (2.3%) 2 (2.4%) 9 (6.8%) 6 (20.7%) 4 (5.9%) 0 (0.0%)
Recurrent angina* 30 (13.9%) 20 (23.8%) 24 (18.2%) 4 (13.8%) 22 (32.4%) 4 (36.4%)
Artificial ventilation* 0 (0.0%) 4 (4.8%) 12 (9.1%) 19 (65.5%) 5 (7.4%) 0 (0.0%)
Atrial arrhythmia* 7 (3.2%) 9 (10.7%) 19 (14.4%) 6 (20.7%) 3 (4.4%) 1 (9.1%)
Cardiac arrest* 2 (0.9%) 4 (4.8%) 6 (4.5%) 18 (62.1%) 3 (4.4%) 0 (0.0%)
Coronary angiography 39 (18.1%) 17 (20.2%) 0 (0.0%) 3 (10.3%) 68 (100%) 11 (100%)
Inotropic agents 0 (0.0%) 5 (6.0%) 10 (7.6%) 14 (48.3%) 6 (8.8%) 1 (9.1%)
PTCA 14 (6.5%) 7 (8.3%) 0 (0.0%) 2 (6.9%) 28 (41.2%) 0 (0.0%)
ET maximum HR (beats/min) 116 6 1.7 114 6 2.0 — — — —
*p , 0.05 for the F value in the analysis of variance; significant differences between the individual groups (by the least significant differences test) are outlined in the text.
CABGP 5 coronary artery bypass surgery group; CAGP 5 coronary angiography/angioplasty group; CCF 5 congestive cardiac failure; CK 5 creatine kinase; EETGP 5
early exercise test group; ET 5 exercise test; HR 5 heart rate; LETGP 5 late exercise test group; NETGP 5 no exercise test group; PTCA 5 percutaneous transluminal
coronary angiography; VT 5 ventricular tachycardia; VF 5 ventricular fibrillation.
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study by Juneau et al. (12) compared symptom limited ETs
versus a low level test on 202 patients with an AMI. The
symptom limited stress test demonstrated ischemia in 89 of
202 (44.1%) patients while the low level test demonstrated
ischemia in only 56 of 202 (27.7%) patients. The 202
patients included in the above study represented 41% of the
495 patients who survived to hospital discharge. In this
study a similar percentage (40.0%) of patients who survived
to hospital discharge underwent an ET using the BPR
within three days of admission. In contrast, in the study by
Juneau et al. (12), the test was done at a mean of 7.4 6 2.3
days after the AMI. In addition, a Stanford modification of
the Naughton protocol rather than a BPR was used in that
study even for the symptom limited test. A study by Topol
et al. (8) looked at 126 patients who underwent an ET on
day 3 after an AMI. These 126 patients were from a group
of 507 patients admitted with an AMI with 195 patients
undergoing coronary angioplasty. Of the 126 patients more
than 94 patients (74.6%) had undergone prior coronary
angiography with angioplasty performed in 64.4% of those
undergoing angiography. This study used a submaximal ET
with concomitant thallium scintigraphy with termination of
the test at a heart rate of 140 beats/min. In this study, 30
patients (13.9%) achieved a maximum heart rate of .140
with 33 patients (15.7%) exercising beyond stage III of the
BPR. The study by Topol et al. (8) randomized 80 of the
patients with negative ET to early (day 3) discharge versus
the conventional 7–10 day discharge. The study demon-
strated no significant adverse outcomes from the early
discharge. In this study 40.3% of the patients were dis-
charged home the same day after the early ET with another
33.8% discharged the next day. Further, the adoption of
early ET while the patients are still in the CICU has
resulted in shortening of the in-hospital stay for AMI as
demonstrated in a recent study from this institution (9). The
mean length of stay for AMI was 5.1 days in this study (9)
with 53% of the patients directly discharged from the CICU
within 4 days. Several other studies have demonstrated the
usefulness of ET in patients with unstable angina or AMI
although the ETs were performed much later in the hospital
course (5–14 days after admission) or using less intense
protocols (13,14).
Safety concerns with early ET. The reason for avoiding
early ET after AMIs generally appears to be related to the
concern regarding safety. This study demonstrated that
immediate complications related to the ET were negligible
with almost all adverse effects being reversible and transient
when patients are selected based on their clinical course in
the CICU. Thus, acute myocardial rupture, a complication
that is possible and probably fatal when it occurs, was not
observed in this study. However, the occurrence of myocar-
dial rupture during an ET would still remain a possibility
and a concern when large numbers of patients are tested
early using a BPR as this study was limited to only 216
patients. Nevertheless, these serious events occur after
AMIs in a minority of individuals even without exercise.
Only a randomized control study comparing early versus
late ET using the BPR would resolve the above issue if early
ET would result in or predispose to cardiac rupture. As the
incidence of cardiac rupture is very small, it is unlikely that
such a study would ever be conducted due to the require-
ment of a very large number of patients. Cardiac rupture
during exercise may be more likely to occur with larger
Table 4. Follow-up Information on the Patients Discharged Alive (n 5 510; the Number of Patients, With Percentages Within that
Group in Brackets)
EETGP LETGP NETGP CAGP CABGP
No. of Patients 216 (42.3%) 83 (16.3%) 132 (25.9%) 68 (13.3%) 11 (2.2%)
Discharge Medications
Ace-inhibitor* 69 (31.9%) 46 (55.4%) 65 (49.2%) 28 (41.2%) 4 (36.4%)
Beta-blockers 187 (86.6%) 77 (92.8%) 81 (61.4%) 57 (83.8%) 8 (72.7%)
Calcium antagonist 18 (8.3%) 3 (3.6%) 25 (18.9%) 6 (8.8%) 3 (27.3%)
Six-week Follow-up
Unscheduled return visits 49 (22.7%) 22 (26.5%) 32 (24.2%) 23 (33.8%) 2 (18.2%)
Readmissions 19 (8.8%) 12 (14.5%) 20 (15.1%) 6 (8.8%) 0 (0.0%)
Emergency room visits 26 (12.0%) 11 (13.2%) 9 (6.8%) 14 (20.6%) 2 (18.2%)
Return to work† 45.4% (40/88) 27.6% (8/29) INS 23.5% (4/17) INS
One-Year Follow-up**
Death* 4.0% 8.8% 34.9% 15.4% 9.1%
Unstable angina 4.9% 6.9% 10.8% 10.5% 9.1%
Recurrent MI 4.9% 7.0% 9.6% 7.0% 0.0%
Cardiac failure* 1.1% 4.2% 12.9% 5.3% 0.0%
Coronary angioplasty 6.4% 9.8% 5.5% 7.1% 0.0%
*p , 0.05 for the F value in the analyses of variance. Significant differences between the individual groups (using the Bonferonni’s intervals) are outlined in the text. †On those
employed at admission.
CABGP 5 coronary artery bypass surgery group; CAGP 5 coronary angiography/angioplasty group; EETGP 5 early exercise test group; INS 5 insufficient number of
patients employed at time of admission for meaningful data (NETGP 5 9 patients, CABGP 5 1 patient); LETGP 5 late exercise test group; NETGP 5 no exercise test group.
**One-year follow-up was available on 484 of the 497 eligible patients, that is, 540—30 (died before discharge)—13 (not reached one-year yet) 5 497.
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infarctions. In this study the EETGP had a mean creatine
kinase peak, which was significantly less than that for
LETGP. This suggests an appropriate clinical decision by
the attending cardiologist who deemed patients with large
AMIs to be not “ready” for ET as early as the patients with
smaller myocardial infarctions. Nevertheless, the mean cre-
atine kinase peak of 1441 6 225 u/l for the EETGP
suggests that this group did not constitute a population with
very small infarctions. Further, even with a large AMI,
delaying the ET by two to three days may not necessarily
result in reduction in the incidence of myocardial rupture.
Data from a questionnaire dealing with 151,949 ETs
done at 193 institutions within four weeks of an AMI
revealed a mortality rate of 0.03% (fatal AMI, fatal cardiac
arrest or rupture), a major nonfatal adverse event (nonfatal
AMI or resuscitated cardiac arrest) rate of 0.09% and a
minor complication rate of 1.5% (15). Thus, a small but
definite incidence of serious complications will be expected
with ET after an AMI, even when the test is delayed to a
much later time.
Another complication that should be considered with ET
using an aggressive protocol would be the development of
ventricular aneurysms precipitated by infarct expansion due
to the higher systolic blood pressures and heart rates
attained during exercise. In the study by Topol et al. (8), no
ventricular aneurysms were noted during a follow-up period
on those who underwent ET at day 3. However, this study
used a submaximal ET. The expected risk of precipitating
aneurysm formation is low, as ET results in an increased
systolic blood pressure and heart rate only for a very short
period of time. The development of ventricular aneurysms
are more likely influenced by persistent tachycardia and
hypertension. Nevertheless, whether early ET using an
aggressive protocol, such as the BPR, results in worsening of
infarct expansion can only be determined by a randomized
trial.
Advantages of early ET. These are several:
1) the patients with positive tests for ischemia could be
selected for early coronary angiography (to consider
revascularization) thereby shortening their ultimate
length of stay,
2) those with negative tests for ischemia can be discharged
home without further delay reducing overall hospital
costs associated with the management of the myocar-
dial infarction,
3) the higher levels of exercise attained with the BPR in
younger patients would give them a greater sense of
confidence in terms of returning to regular activities at
home and work over the ensuing weeks.
The use of the modified Bruce/Naughton protocols for
predischarge ET with the test terminated at 5–6 metabolic
equivalent of time may impart a sense of apprehension in
patients who felt exercise had to be limited to very low levels
after discharge. This was especially so in the case of patients
who were physically active in terms of regular exercise before
the AMI. In the present institution, individuals with small/
moderate AMIs who are able to complete stage II of the
BPR are started on cardiac rehabilitation exercise programs
within two weeks of the myocardial infarction enabling
them to return to full-time work much earlier than previ-
ously. In this study 45.4% of the patients (who were
employed at the time of admission) had returned to work
within six weeks of the onset of the AMI.
Follow-up data. As demonstrated, early ET did not appear
to result in any increase of unscheduled return visits (to
family doctor, medicenter or emergency department) or
readmissions within a six-week period after discharge; the
rates for these events remained the same or lower as
compared with the LETGP. However, as the EETGP and
LETGP are two separate populations, one cannot exclude
the possibility of an increase in these events by early exercise
testing. This study is limited in this respect being observa-
tional in nature and not a randomized trial of early ET
versus late ET or early ET versus no ET. However, such a
randomized trial is unlikely to be performed (at least in
Canada) given the current economic constraints. During the
ensuing year there appeared to be a trend towards a lower
incidence of coronary events (including death, unstable
angina, development of congestive cardiac failure and the
need for coronary angioplasty) as expected in the EETGP
compared with the LETGP given the smaller size of the
AMIs in the former group. However, recurrent AMI rate
appeared to be similar or higher in the EETGP paralleling
the higher percentage of non-Q AMIs in the EETGP.
This study confirms the high in-hospital as well as
longer-term morbidity and mortality of the group of pa-
tients unable to undergo a predischarge ET (NETGP in
this study) as has been shown previously (7). This is in spite
of the fact that their infarct size did not appear to be larger
based on the creatine kinase peak of 1544 6 147 U/l
compared with the EETGP (1441 6 225 U/l, p . 0.05).
The NETGP were an older group of patients with a higher
percentage of non–Q myocardial infarctions. Further, the
inability to perform an ET in their group was not related to
ongoing angina but rather to physical limitations. This
study suggests that special emphasis should be placed on the
NEGTP to minimize the occurrence of future coronary
events. Pharmacologic-stress imaging in this group of pa-
tients will likely help to further risk stratify, by identifying
those with reversibly ischemia. However, it remains to be
proven whether coronary angiography with revasculariza-
tion, performed when indicated and feasible, would alter the
prognosis in a favorable manner as the risks of intervention
are also likely going to be higher in this group of older
patients with physical limitations. In this regard it is
interesting that the NETGP did not demonstrate a signif-
icantly higher incidence of re-infarction and the occurrence
of unstable angina compared with the other groups, while
demonstrating a higher incidence of the occurrence of
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congestive cardiac failure. This may suggest that the higher
mortality may be related to impaired left ventricular func-
tion rather than ischemic events. Further, the higher mor-
tality is likely, at least partly, related to concurrent illnesses,
which may not be easily amendable to disease modification.
Conclusions. In summary, this study demonstrates that
ET within two to three days of an AMI (without discon-
tinuation of beta-blocker, if already commenced) is a feasi-
ble and safe strategy in a significant proportion of patients
admitted with a myocardial infarction. This could lead to
early triage with expected cost savings.
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